Discovering the differences between craniopharyngiomas that regrow after treatment and those that don't
Molecular profiling of relapsing craniopharyngioma
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Molecular profiling of relapsing craniopharyngioma
Brain distribution models to select polymer-delivered drugs for the treatment of childhood brain cancers
Identifying the metabolic ‘Achilles Heel’ of childhood brain cancers
Defining the cellular origins of neonatal and paediatric brain tumours
In vitro evaluation of the potential of glucose restriction as an adjuvant therapy for paediatric brain tumours